- Home
- IVVD vs MPAA Comparison
IVVD vs MPAA Comparison
Compare IVVD & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVVD | MPAA |
|---|---|---|
| Founded | 2020 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.6M | 202.6M |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | IVVD | MPAA |
|---|---|---|
| Price | $0.59 | $10.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $10.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 4.1M | 81.2K |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 79.02 | ★ 162.63 |
| EPS | ★ N/A | N/A |
| Revenue | $53,426,000.00 | ★ $789,806,000.00 |
| Revenue This Year | $12.40 | $0.60 |
| Revenue Next Year | $44.85 | $4.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 110.47 | 4.28 |
| 52 Week Low | $0.53 | $9.29 |
| 52 Week High | $3.07 | $18.12 |
Technical Indicators
Market Signals| Indicator | IVVD | MPAA |
|---|---|---|
| Relative Strength Index (RSI) | 38.92 | 45.07 |
| Support Level | $0.53 | $9.98 |
| Resistance Level | $1.02 | $10.95 |
| Average True Range (ATR) | 0.05 | 0.37 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 19.46 | 38.75 |
Price Performance
Historical ComparisonAbout IVVD Invivyd Inc.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts, test solutions, and diagnostic equipment. Its replacement parts are mainly sold to automotive retail chain stores, warehouse distributors across North America, and automobile manufacturers for aftermarket and warranty replacement programs. The Company's test solutions and diagnostic equipment serve the automotive component and powertrain testing market. Its product portfolio includes rotating electrical products such as alternators and starters; brake-related products including brake calipers, brake rotors, brake pads, brake master cylinders, and wheel hub assemblies and bearings; and other products. Its segments are Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty.